A detailed history of Mather Group, Llc. transactions in Penumbra Inc stock. As of the latest transaction made, Mather Group, Llc. holds 100 shares of PEN stock, worth $23,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 137 27.01%
Holding current value
$23,784
Previous $24,000 20.83%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$163.64 - $210.12 $6,054 - $7,774
-37 Reduced 27.01%
100 $19,000
Q2 2024

Jul 08, 2024

BUY
$172.27 - $223.95 $861 - $1,119
5 Added 3.79%
137 $24,000
Q1 2024

Apr 08, 2024

BUY
$220.09 - $273.15 $29,051 - $36,055
132 New
132 $29,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.01B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.